Clinical disease caused by weakly pathogenic mycobacterial species, which is known as Mendelian susceptibility to mycobacterial disease (MSMD), is a rare entity. IFN-γ and IL-17 production are defective due to insufficient response to IL-2 and IL-23 in IL-12Rβ1 deficiency; so this also causes tendency to intracellular microorganisms and candidal diseases. Here, we present a patient who suffers IL-12Rβ1 deficiency caused by a novel bi-allelic mutation with recurrent salmonellosis, mycobacterial, fungal infections and remained asymptomatic during 13 months of follow-up after hIFN-γ treatment. In addition she had hemolytic anemia and midline defects like cleft lip and palate which have not been reported in a patient with MSMD in the literature prior to this case report. In conclusion, diagnosis of MSMD should be kept in mind in patients with recurrent salmonellosis, mycobacterial and fungal infections especially in countries with a high consanguinity rate.
Mendelian susceptibility to mycobacterial disease (MSMD; MIM 209950) is a clinical syndrome that predisposes otherwise apparently healthy individuals to infections caused by weakly virulent mycobacteria, such as Bacille Calmette-Guérin (BCG) and environmental mycobacteria (EM; also known as atypical or nontuberculous mycobacteria), Salmonella and Candida 1 . Since 1996, MSMD-causing mutations have been identified in 9 genes 2 . Seven of these genes are autosomal and encode the 2 chains of the interferon (IFN)-γ receptor (IFNGR1 and IFNGR2): the signal transducer and activator of transcription factor 1 (STAT1), the p40 subunit of interleukin (IL)-12 and IL-23 (IL12B), the β1 chain shared by the IL-12 and IL-23 receptors (IL12RB1), the transcription factor of IFN regulatory factor 8 (IRF8), and ISG15, the IFN-stimulated gene 15 (ISG15) 2 . Two genes are located in chromosome X; encodes nuclear factor-κB essential modulator (NEMO) and cytochrome beta chain (CYBB) 3 . The most common genetic etiology of MSMD is autosomal recessive (AR) IL-12Rβ1 deficiency, first reported in 1998 4 . IL-12Rβ1 deficiency is often, but not always, symptomatic. The clinical phenotype is very heterogenous and mycobacterial infections are the most frequent infections. It typically begins in childhood and is lethal in up to a third of patients, particularly in patients with EM disease, and its prognosis seems to improve with age 5 . A majority of the patients suffers also salmonellosis and a 27% of reported patients also develop fungal disease, especially due to Candida 2, 6 . The association of IL-12RR1 deficiency with other inherited diseases (due to mutations in other genes), including α1-antitrypsin deficiency, ataxia-telangiectasia, neurofibromatosis, and thrombophilia has been reported; and this deficiency has also been reported to be associated with other diseases of no known genetic etiology, such as IgA deficiency 2 . Here, we present a case of IL-12Rβ1 deficiency with fungal infection and Salmonellosis associated with other clinical manifestations, such as autoimmune hemolytic anemia and cleft lip and palate.
Case Report
Patient was born in Turkey in 2005. She was the third child of consanguineous Turkish parents. Her family history was unremarkable including two healthy brothers ( Fig. 1 and 2A) . She was vaccinated with BCG at age 2 months without secondary effects. She had been operated for cleft palate and lip at 4.5 month-old and 18 months old, respectively (Fig. 1A) . At 18 months of age, she had been suffering from recurrent oral moniliasis and lymphadenopathies (LAPs), culture was negative for all microbes, including mycobacteria. At 5 and a half year-old, she was referred for persistent LAPs, long lasting fever and recurrent oral moniliasis. Past history (Fig. 2B ). In addition, T-blasts from the patient did not express IL-12Rβ1 in surface (Fig.  2C) . Genetical evaluation by Sanger method revealed a novel homozygous mutation (R211X) in exon 7 in the IL12RB1 gene (Fig. 2D) . Both parents and one brother are heterozygous for this mutation; and a second brother is wild type (Fig. 2D) . IL-17 percentages and mean fluorescence intensities expressed by CD4+T cells were found to be low both before and after in vitro stimulation by PMA-Iono when compared with the healthy control as described in patients with IL-12Rβ1 deficiency (Fig. 3) 7 .
On follow-up, she was re-hospitalized due to inguinal lymphadenitis due to Salmonella infection. Recombinant hIFN-γ (Imukin) was given at the recommended dosage of 50 μg/m 2 by subcutaneous route three times a week. The patient remained asymptomatic during 13 months of follow-up after hIFN-γ treatment. She received prophylaxis with fluconazole.
Discussion
We describe here a patient with salmonellosis, mycobacterial and fungal infections. The patient suffers a IL-12Rβ1 deficiency caused by a novel bi-allelic mutation. In addition she had hemolytic anemia and midline defects like cleft lip and palate. Up to date, these two last components has not been reported in a patient with IL-12Rβ1 deficiency in the literature prior to this case report.
Chronic mucocutaneous candidiasis (CMC) is a striking feature of some immunodeficiencies. Also about 27 % of IL-12p40-and IL-12Rβ1 deficient patients also suffer from mild signs of CMC (but not dermatophytosis), even when not clinically ill from other infections or on antibiotic treatment 2,4,5 . The common defect detected in these diseases seems to be IL-17 deficiency, which causes defective cutaneous antifungal immunity 8 18 previously reported that three diverse immune stimulators, CFA, GM-CSF, and IFN-γ, each significantly reduced the incidence of birth defects caused by diabetes mellitus. So, IFN-γ deficiency could be related with midline fusion defects. Identification of IL12RB1 mutation in the patient was made by Sanger method. As the patient was born to a consanguineous family, probably another mutation located in another gene could explain this association. New technologies in genetics, such as exomesequencing or Copy Number variation (CNV) could discover the genetic cause of this defect.
In conclusion; IFN-γ and IL-17 production are defective due to insufficient response to IL-2 and IL-23 in IL-12Rβ1 deficiency; so this causes tendency to intracellular microorganisms and candidal diseases. Our case differs regarding marked oral moniliasis, lymphadenopathies, accompanied by autoimmunity and cleft lip and palate with a novel bi-allelic mutation in the IL12RB1 gene. Diagnosis of MSMD should be kept in mind in countries in which consanguinity rate is high and BCG vaccine administration is routine in early infancy. Both curative and preventive treatment of IL-12Rβ1 deficiency, based on prolonged courses of antibiotics, exogenous IFN-γ treatment and, in rare cases, surgical resection of affected areas, may influence clinical outcome in these patients.
